Literature DB >> 33567864

Cancer Therapy-Associated Thrombosis.

Steven P Grover1, Yohei M Hisada1, Raj S Kasthuri1, Brandi N Reeves1, Nigel Mackman1.   

Abstract

[Figure: see text].

Entities:  

Keywords:  blood coagulation; drug therapy; neoplasms; thrombosis

Mesh：

Substances：

Year:  2021        PMID： 33567864      PMCID： PMC7990713          DOI： 10.1161/ATVBAHA.120.314378

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


  165 in total

1.  Thalidomide causes platelet activation, which can be abrogated by aspirin.

Authors:  S Dunkley; L Gaudry
Journal:  J Thromb Haemost       Date:  2007-06       Impact factor: 5.824

2.  Tamoxifen and thrombosis.

Authors:  K Nevasaari; M Heikkinen; P J Taskinen
Journal:  Lancet       Date:  1978-10-28       Impact factor: 79.321

Review 3.  Arterial Thrombosis in Cancer: Spotlight on the Neglected Vessels.

Authors:  Maria Laura Canale; Irma Bisceglia; Chiara Lestuzzi; Iris Parrini
Journal:  Anticancer Res       Date:  2019-09       Impact factor: 2.480

4.  Induction of macrophage procoagulant expression by cisplatin, daunorubicin and doxorubicin.

Authors:  H R Wheeler; C L Geczy
Journal:  Int J Cancer       Date:  1990-10-15       Impact factor: 7.396

Review 5.  Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis.

Authors:  Shobha Rani Nalluri; David Chu; Roger Keresztes; Xiaolei Zhu; Shenhong Wu
Journal:  JAMA       Date:  2008-11-19       Impact factor: 56.272

6.  Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib.

Authors:  Yllka Latifi; Federico Moccetti; Melinda Wu; Aris Xie; William Packwood; Yue Qi; Koya Ozawa; Weihui Shentu; Eran Brown; Toshiaki Shirai; Owen J McCarty; Zaverio Ruggeri; Javid Moslehi; Junmei Chen; Brian J Druker; Jose A López; Jonathan R Lindner
Journal:  Blood       Date:  2019-01-28       Impact factor: 25.476

7.  Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ROS production in endothelial cells and cardiomyocytes.

Authors:  Chiara Focaccetti; Antonino Bruno; Elena Magnani; Desirée Bartolini; Elisa Principi; Katiuscia Dallaglio; Eraldo O Bucci; Giovanna Finzi; Fausto Sessa; Douglas M Noonan; Adriana Albini
Journal:  PLoS One       Date:  2015-02-11       Impact factor: 3.240

8.  Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer.

Authors:  Ella Grilz; Oliver Königsbrügge; Florian Posch; Manuela Schmidinger; Robert Pirker; Irene M Lang; Ingrid Pabinger; Cihan Ay
Journal:  Haematologica       Date:  2018-05-24       Impact factor: 9.941

9.  Defective angiogenesis delays thrombus resolution: a potential pathogenetic mechanism underlying chronic thromboembolic pulmonary hypertension.

Authors:  Sherin Alias; Bassam Redwan; Adelheid Panzenboeck; Max P Winter; Uwe Schubert; Robert Voswinckel; Maria K Frey; Johannes Jakowitsch; Arman Alimohammadi; Lukas Hobohm; Andreas Mangold; Helga Bergmeister; Maria Sibilia; Erwin F Wagner; Eckhard Mayer; Walter Klepetko; Thomas J Hoelzenbein; Klaus T Preissner; Irene M Lang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-13       Impact factor: 8.311

10.  Effect of chemotherapy and longitudinal analysis of circulating extracellular vesicle tissue factor activity in patients with pancreatic and colorectal cancer.

Authors:  Raj S Kasthuri; Yohei Hisada; Anton Ilich; Nigel S Key; Nigel Mackman
Journal:  Res Pract Thromb Haemost       Date:  2020-03-09
View more
  11 in total

Review 1.  Cardiac Remodelling Following Cancer Therapy: A Review.

Authors:  Tan Panpan; Du Yuchen; Shi Xianyong; Liu Meng; He Ruijuan; Dong Ranran; Zhang Pengyan; Li Mingxi; Xie Rongrong
Journal:  Cardiovasc Toxicol       Date:  2022-07-25       Impact factor: 2.755

Review 2.  Thromboembolism and Immune Checkpoint Blockade in Cancer Patients: An Old Foe for New Research.

Authors:  Mireille Langouo Fontsa; Marco Maria Aiello; Edoardo Migliori; Mario Scartozzi; Matteo Lambertini; Karen Willard-Gallo; Cinzia Solinas
Journal:  Target Oncol       Date:  2022-09-14       Impact factor: 4.864

Review 3.  Cancer-associated venous thromboembolism.

Authors:  Alok A Khorana; Nigel Mackman; Anna Falanga; Ingrid Pabinger; Simon Noble; Walter Ageno; Florian Moik; Agnes Y Y Lee
Journal:  Nat Rev Dis Primers       Date:  2022-02-17       Impact factor: 65.038

Review 4.  In situ Pulmonary Artery Thrombosis: A Previously Overlooked Disease.

Authors:  Yunshan Cao; Chao Geng; Yahong Li; Yan Zhang
Journal:  Front Pharmacol       Date:  2021-07-08       Impact factor: 5.810

5.  Can thromboprophylaxis build a link for cancer patients undergoing surgical and/or chemotherapy treatment? The MeTHOS cohort study.

Authors:  Spyridon Xynogalos; David Simeonidis; George Papageorgiou; Abraham Pouliakis; Nikolaos Charalambakis; Evangelos Lianos; Evridiki Mazlimoglou; Alexandros-Nikolaos Liatsos; Christos Kosmas; Nicolaos Ziras
Journal:  Support Care Cancer       Date:  2022-05-12       Impact factor: 3.359

6.  The Efficacy of the Systemic Immune-Inflammation Index and Prognosis Nutritional Index for the Diagnosis of Venous Thromboembolism in Gastrointestinal Cancers.

Authors:  Lu Zhang; Yue Fang; Jianghao Xing; Hao Cheng; Xiaonan Sun; Zhichao Yuan; Yidan Xu; Jiqing Hao
Journal:  J Inflamm Res       Date:  2022-08-15

7.  Safety Assessment on Serious Adverse Events of Targeted Therapeutic Agents Prescribed for RAS Wild-Type Metastatic Colorectal Cancer: Systematic Review and Network Meta-Analysis.

Authors:  Yeo Jin Choi; Chang-Young Choi; Sandy Jeong Rhie; Sooyoung Shin
Journal:  Int J Environ Res Public Health       Date:  2022-07-27       Impact factor: 4.614

8.  One-Year Incidences of Venous Thromboembolism, Bleeding, and Death in Patients With Lung Cancer (Cancer-VTE Subanalysis).

Authors:  Nobuyasu Awano; Tetsuya Okano; Riken Kawachi; Masaru Matsumoto; Tetsuya Kimura; Atsushi Takita; Mari S Oba; Hideo Kunitoh
Journal:  JTO Clin Res Rep       Date:  2022-08-08

9.  Molecular Landscape of the Coagulome of Oral Squamous Cell Carcinoma.

Authors:  Marine Lottin; Simon Soudet; Julie Fercot; Floriane Racine; Julien Demagny; Jérémie Bettoni; Denis Chatelain; Marie-Antoinette Sevestre; Youcef Mammeri; Michele Lamuraglia; Antoine Galmiche; Zuzana Saidak
Journal:  Cancers (Basel)       Date:  2022-01-17       Impact factor: 6.639

Review 10.  Novel Mechanisms of Anthracycline-Induced Cardiovascular Toxicity: A Focus on Thrombosis, Cardiac Atrophy, and Programmed Cell Death.

Authors:  Silvio Antoniak; Sukanya Phungphong; Zhaokang Cheng; Brian C Jensen
Journal:  Front Cardiovasc Med       Date:  2022-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.